Thromb Haemost 1990; 64(02): 312-318
DOI: 10.1055/s-0038-1647308
Original Article
Schattauer GmbH Stuttgart

Selenium Dependent Glutathione Peroxidase: A Physiological Regulatory System for Platelet Function

G Perona
The Divisione di Ematologia, Istituto di Patologia Speciale Medica, Italy
,
R Schiavon
*   Istituto di Chimica e Microscopia Clinica, Italy
,
G C Guidi
*   Istituto di Chimica e Microscopia Clinica, Italy
,
D Veneri
The Divisione di Ematologia, Istituto di Patologia Speciale Medica, Italy
,
P Minuz
**   Istituto di Clinica Medica University of Verona, Verona, Italy
› Author Affiliations
Further Information

Publication History

Received 30 January 1990

Accepted after revision01 May 1990

Publication Date:
25 July 2018 (online)

Summary

In human platelets the selenoenzyme glutathione peroxidase (GSH-Px) acts as a scavenger of the peroxides generated during the burst of arachidonic acid (AA) metabolism. Such a mechanism inhibits the biosynthesis of both thromboxane A2 (TXA2) and lipoxygenase products. The same mechanism is not effective on the prostacyclin (PGI2) biosynthesis from cultured endothelial cells. In order to evaluate this effect in vivo, besides in vitro, we activated the enzyme in eight normal volunteers by increasing their daily Se intake for 8 weeks, monitoring: platelet GSH-Px activity, platelet aggregation induced by A A and U 44069, and concurrent malondialdehyde (MDA) and thromboxane B2 (TXB2) production, urinary excretion of renal and systemic TXA2 and PGI2 metabolites, platelet enzyme activities of the hexose monophosphate pathway and glutathione content, platelet adenine nucleotides, bleeding time, plasma Se concentration. We found: a) progressive platelet GSH-Px activation by Se paralleling an enhancement of platelet aggregation threshold values for AA, but not for U 44069; b) concurrent inhibition of platelet biosynthesis of TXA2 both in vitro and in vivo while the biosynthesis of systemic prostacyclin was unaffected; c) a progressive increase in the bleeding time, unmodified by aspirin. In conclusion, we believe that Se-dependent GSH-Px represents a physiological mechanism regulating the biosynthesis of prostanoids with implications in platelet function and that a Se dietary supplement might be considered in the prevention of arterial thrombosis.

 
  • References

  • 1 Salonen TJ, Alfthan G, Huttunen JC, Pikkarainen J, Puska P. Association between cardiovascular death and myocardial infarction and serum selenium in a matched-paired longitudinal study. Lancet 1982; 2: 175-179
  • 2 Moore JA, Noiva R, Wells JC. Selenium concentrations in plasma of patients with arteriographically defined coronary atherosclerosis. Clin Chem 1984; 30: 1171-1173
  • 3 Zumkley H. Clinical aspects of selenium metabolism. Biol Trace Elem Res 1988; 15: 139-146
  • 4 Jackson ML. Selenium: geochemical distribution and associations with human heart and cancer death rates and longevity in China and the United States. Biol Trace Elem Res 1988; 15: 13-21
  • 5 Wang YX, Bocher K, Reuter H, Kiem J, Kasperek K, Iyengar GV, Loogen F, Gross R, Feinenendegen LE. Selenium and myocardial infarction: glutathione peroxidase in platelets. Klin Wochenschr 1981; 59: 817-818
  • 6 Guidi GC, Schiavon R, Sheiban I, Perona G. Platelet glutathione peroxidase activity is impaired in patients with coronary heart disease. Scand J Clin Lab Invest 1986; 46: 549-551
  • 7 Flohe L, Gunzler WA, Schock HH. Glutathione peroxidase: a selenoenzyme. FEBS Lett 1973; 32: 132-4
  • 8 Flohe L, Gunzler WA. Glutathione peroxidase. In: Glutathione Flohe L, Benoehr HCh, Sies H, Waller HD, Wendel A. (eds) Georg Thieme; Stuttgart: 1974: 132-145
  • 9 Flohe L, Gunzler WA, Ladenstein R. Glutathione peroxidase. In: Glutathione Arias IM, Jakoby WB. (eds) Raven Press; New York: 1976: 115-135
  • 10 Ganther HE, Hafeman DG, Lawrence RA, Serf ass RE, Hoekstra YG. Selenium and glutathione peroxidase in health and disease. In: Trace elements in human health and disease Prasad A. (ed) Academic Press; New York: 1976: 165-234
  • 11 Wilson PS, Judson GJ. Glutathione peroxidase activity in bovine and ovine erythrocytes in relation to blood selenium concentration. Br Vet J 1976; 132: 428-34
  • 12 Perona G, Cellerino R, Guidi GC, Moschini G, Stievano BM, Tregnaghi C. Erythrocytic glutathione peroxidase: its relationship with plasma selenium in man. Scand J Haematol 1977; 19: 116-120
  • 13 Perona G, Guidi GC, Piga A, Cellerino R, Menna R, Zatti M. In vivo and in vitro variations of human erythrocyte glutathione peroxidase activity as result of cells aging, selenium availability and peroxide activation. Br J Haematol 1978; 39: 399-408
  • 14 Perona G, Guidi GC, Piga A, Cellerino R, Milani G, Colautti P, Moschini G, Stievano BM. Neonatal erythrocyte glutathione peroxidase deficiency as a consequence of selenium imbalance during pregnancy. Br J Haematol 1979; 42: 567-574
  • 15 Levander OA, Alfthan G, Arvilommi H, Gref CG, Huttunen JK, Kataya M, Koivistoinen P, Pikkarainen J. Bioavailability of selenium to Finnish men as assessed by platelet glutathione peroxidase activity and other blood parameters. J Clin Nutr 1983; 37: 887-897
  • 16 Kasperek K, Iyengar GV, Kiem J, Borberg H, Feinendegen LE. Elemental composition of platelets. Part III. Determination of AG, Au, Cd, Co, Cr, Cs, Mo, Rb, Sb and Se in normal human platelets by neutron activation analysis. Clin Chem 1979; 25: 711-715
  • 17 Guidi GC, Schiavon R, Biasioli A, Perona G. The enzyme glutathione peroxidase in arachidonic acid metabolism of human platelets. J Lab Clin Med 1984; 104: 574-582
  • 18 Lands WE M, Lee R, Smith WL. Factors regulating the biosynthesis of reduced prostaglandins. Ann NY Acad Sci 1971; 180: 107-122
  • 19 Smith WL, Lands WE M. Oxygenation of poliunsaturated fatty acids during prostaglandin biosynthesis by sheep vesicular glands. Biochemistry 1972; 11: 3276-3285
  • 20 Kulmacz RJ, Lands WE M. Characteristics of prostaglandin H synthase. In: Advances in Prostaglandin, Thromboxane and Leuko-triene Research. Vol. II Samuelsson R, Paoletti R, Ramwell P. (eds) Raven Press; New York: 1973. pp 93-97
  • 21 Egan RW, Paxton J, Kuhel FA. Mechanism for irreversible self deactivation of prostaglandin synthetase. J Biol Chem 1976; 251: 7329-7335
  • 22 Cook HW, Lands WE M. Mechanism of suppression of cellular biosynthesis of prostaglandins. Nature 1976; 260: 630-632
  • 23 Hemler ME, Lands WE M. Evidence for a peroxidase-initiated free radical mechanism of prostaglandin biosynthesis. J Biol Chem 1980; 255: 6253-6260
  • 24 Kulmacz RJ, Lands WE M. Requirements for hydroperoxide by the cyclooxygenase and peroxidase activities of prostaglandin synthase. Prostaglandins 1983; 25: 531-540
  • 25 Schiavon R, Freeman GE, Guidi GC, Perona G, Zatti M, Kakkar VV. Selenium enhances prostacyclin production by cultured endothelial cells: possible explanation for increased bleeding times in volunteers taking selenium as a dietary supplement. Thromb Res 1984; 34: 389-396
  • 26 Committee on Dietary Allowances, Food and Nutrition Board, National Research Council, National Academy of Science, 1980. Recommended Dietary Allowances. 9th revised edition. National Academy of Science, Washington D.C. Quoted by Young V R, Nahapetian A, Jonghorbani M. Selenium bioavailability with reference to human nutrition Am J Clin Nutr 1982; 35: 1076-1088
  • 27 Thomson C, Robinson MF, Campbell DR, Rea HM. Effects of prolonged supplementation with daily supplement of selenomethionine and sodium selenite on glutathione peroxidase activity in blood of New Zealand residents. Am J Clin Nutr 1982; 36: 24-31
  • 28 Jaakkola A, Tummayuori L, Pirinen A, Kurkela P, Tolonen M, Arstila AU. Selenium levels in whole blood of Finnish volunteers before and during organic and inorganic selenium supplementation. Scand J Clin Lab Invest 1983; 43: 473-476
  • 29 Baker SS, Lerman RH, Krey SH, Crocker KS, Hirsh EF, Cohen H. Selenium deficiency with total parenteral nutrition: reversal of biochemical and functional abnormalities by selenium supplementation: a case report. Am J Clin Nutr 1983; 38: 769-774
  • 30 Cohen HJ, Chovaniech ME, Mistretta D, Baker SS. Selenium repletion and glutathione peroxidase. Differential effects on plasma and red blood cell enzyme activity. Am J Clin Nutr 1985; 41: 735-747
  • 31 Brown MR, Cohen HJ, Lyons JM, Curtis TW, Thunberg B, Cochran WJ, Klish WJ. Proximal muscle weakness and selenium deficiency associated with long term parenteral nutrition. Am J Clin Nutr 1986; 43: 549-554
  • 32 Jaffe WG, Ruphael MD, Mondragon MC, Cuevas MA. Biochemical and clinical studies on school children in seleniferous zone. Arch Latinoamer Nutr 1972; 22: 595-611
  • 33 Howe M. Selenium in the blood of south Dakotans. Arch Environ Health 1979; 36: 444-448
  • 34 Yang G, Wang S, Zhou R, Sun S. Endemic selenium intoxication of humans in China. Am J Clin Nutr 1983; 37: 872-881
  • 35 Shamberger RJ. The genotoxicity of selenium. Mutation Res 1985; 154: 29-48
  • 36 Guidi GC, Schiavon R, Zatti M. L’attivita dell’enzima glutatione perossidasi nelle piastrine e nei globuli rossi umani. Giom It Chim Clin 1982; 7: 183-188
  • 37 Gunzler WA, Kremers H, Flohe L. An improved coupled test procedure for glutathione peroxidase (EC 1.11.1.9) in blood. Z Klin Chem Klin Biochem 1974; 12: 444-448
  • 38 Beutler E. Red Cell Metabolism (2nd edition). Grune and Stratton; New York: 1975. pp 1-160
  • 39 Glock GE, McLean P. Further studies on the properties and assay of glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase of rat liver. Biochem J 1953; 55: 400-408
  • 40 Hissin PJ, Russell H. A fluorimetric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 1976; 74: 214-226
  • 41 Holmsen H, Storm E, Day HY. Determination of ATP and ADP in blood platelets: a modification of the firefly luciferase assay for plasma. Anal Biochem 1972; 46: 489-501
  • 42 Malmsten C. Some biological effects of prostaglandin endoperoxide analogs. Life Sci 1976; 18: 169-176
  • 43 Granstrom HE, Kindahl H. Radioimmunoassay of prostaglandins and thromboxanes. In: Advances in Prostaglandin and Thromboxane Research 5 Frölich J J. (ed) Raven Press; New York: 1978. pp 119-210
  • 44 Smith JB, Ingerman CM, Silver MJ. Malondialdehyde formation as an indicator of prostaglandin production by human platelets. J Lab Clin Med 1976; 88: 167-172
  • 45 Fitzgerald GA, Pedersen AK, Patrono C. Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease. Circulation 1983; 67: 1174-1177
  • 46 Catella F, Nowak J, Fitzgerald GA. Measurement of renal and non-renal eicosanoid synthesis. Am J Med 1986; 81: 23-29
  • 47 Vesterqvist O. Measurements of the in vivo synthesis of thromboxane and prostacyclin in humans. Scand J Clin Lab Invest 1988; 48: 401-407
  • 48 Minuz P, Covi G, Paluani F, Degan M, Lechi C, Corsato M, Lechi A. Altered excretion of prostaglandin and thromboxane metabolites in pregnancy-induced hypertension. Hypertension 1988; 11: 550-556
  • 49 Buso GP, Colautti P, Moschini G, Xusheng H, Stievano BM. High sensitivity PIXE determination of selenium in biological samples using a preconcentration technique. Nucl Instr Meth Phys Res 1984; 231: 177-180
  • 50 Mielke Jr CH, Kaneshiro MM, Maher IA, Weiner IM, Rapaport SI. The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood 1969; 34: 204-215
  • 51 Combs GF, Combs SB. Selenium in human nutrition and health. In: The role of selenium in nutrition Combs GF. (ed) Academic Press; New York: 1986. pp 327-343
  • 52 Ramos Martinez JI, Launay JL, Dreux C. A sensitive fluorimetric microassay for the determination of GSH-Px activity. Application to human blood platelets. Anal Biochem 1979; 98: 154-159
  • 53 Thomson CD, Ong LK, Robinson MF. Effects of supplementation with high-selenium wheat bread on selenium, glutathione peroxidase and related enzymes in blood components of New Zealand residents. Am J Clin Nutr 1985; 41: 1015-1022
  • 54 Szeinber A, Golan R, Ben-Ezzer J, Sarova-Pinhas I, Kindler D. Glutathione peroxidase activity in various types of blood cells in multiple sclerosis. Acta Neurol Scand 1981; 63: 67-75
  • 55 Stead NW, Leonard S, Carroll R. Effect of selenium supplementation on selenium balance in the dependent elderely. Am J Med Sci 1984; 290: 228-233
  • 56 Knapp HR, Reilly IA G, Alessandrini P, Fitzgerald GA. In vivo indices of platelet and vascular function during fish oil administration in patients with atherosclerosis. N Engl J Med 1986; 314: 937-942
  • 57 Patrono C, Ciabattoni C, Pugliese F, Pierucci A, Blair IA, Fitzgerald GA. Estimated rate of thromboxane secretion into the circulation of normal humans. J Clin Invest 1986; 77: 590-594
  • 58 Rosenkranz B, Fischer C, Wiemer KE, Frolich JC. Metabolism of prostacyclin and 6-keto-prostaglandin Fla in man. J Biol Chem 1980; 255: 10194-10198
  • 59 Housset B, Junod AF. Effects of culture conditions and hyperoxia on antioxidant enzymes in pig pulmonary artery and aortic endothelium. Biochim Biophys Acta 1982; 716: 283-289
  • 60 Ham EA, Egan RW, Soderman DD, Gale PH, Kuehl Jr FA. Peroxidase-dependent deactivation of prostacyclin synthetase. J Biol Chem 1979; 254: 2191-2194
  • 61 Bryant RW, Simon TC, Bailey JM. Role of glutathione peroxidase and hexose monophosphate shunt in the platelet lipoxygenase pathway. J Biol Chem 1982; 257: 14937-14943
  • 62 Walter Bowie EI, Owen CA. The clinical and laboratory diagnosis of hemorrhagic disorders. In: Disorder of Hemostasis Ratnoff OD, Forbes CD. (eds) Grune and Stratton; New York: 1984. pp 43-72
  • 63 Fitzgerald GA, Oates JA, Hawinger J, Maas RL, Roberts LJ, Brash AR. Endogenous synthesis of prostacyclin and thromboxane and platelet function during chronic aspirin administration in man. J Clin Invest 1983; 71: 676-688
  • 64 Patrono C, Ciabattoni G, Partrignani P, Pugliese F, Filabozzi P, Catella F, Davi G, Forni L. Clinical pharmacology of platelet cyclooxygenase inhibition. Circulation 1985; 72: 1177-1184
  • 65 Vesterqvist O. Rapid recovery of in vivo prostacyclin formation after inhibition by aspirin. Evidence for measurements of the major urinary metabolite of prostacyclin by GC-MS. Eur J Clin Pharmacol 1986; 30: 69-73
  • 66 Oates JA, Fitzgerald GA, Branch RA, Jackson EK, Knapp HR, Jackson Roberts L. Clinical implications of prostaglandin and thromboxane A2 formation. N Engl J Med 1988; 319: 689-698
  • 67 Combs GF, Combs SB. Effects of selenium excesses. In: The Role of Selenium in Nutrition Combs GF. (ed) Academic Press; New York: 1986. pp 463-525
  • 68 Thompson CD, Robinson MF, Campbell DR, Rea HM. Effect of prolonged supplementation with daily supplements of selenomethionine and sodium selenite on glutathione peroxidase activity in blood of New Zealand residents. Am J Clin Nutr 1982; 36: 24-31
  • 69 Brown MR, Cohen HJ, Lyons JM, Curtiss TW, Thumberg B, Cochran WJ, Klish WJ. Proximal muscle weakness and selenium deficiency associated with long term parenteral nutrition. Am J Clin Nutr 1986; 43: 549-554